Bone Densitometers Market Plying for Significant Growth By 2022

Global Bone Densitometers Market Information, by type (central scanners, peripheral scanners and others), by technology (quantitative computed tomography (QCT), radiographic absorptiometry (RA), single x-ray absorptiometry (SXA), dual-energy x-ray absorptiometry (DXA) and others), by end user (hospitals, orthopedic clinics, academic & research institutes and others) - Forecast till 2022 

Bone densitometry is a non-invasive technology that can measure bone mass. Devices useful for this are known as bone densitometers. Market Research Future (MRFR) has published and released a research report about the global bone densitometers market that anticipates aggrandizement for this market with 5.3% CAGR (Compound Annual Growth Rate) during the forecast period between 2016 and 2022. In terms of cash, the market is expected to rise to US $ 1.2 bn. 

Analyzing the market structure, this report evaluates the future growth potential of the market. It observes the strategies of the key players in the market and follows the competitive developments like joint ventures, new product developments, mergers and acquisitions, research and developments (R & D) in the market.

Request Free Sample @ https://www.marketresearchfuture.com/sample_request/2300

The primary reasons for the growth of the global bone densitometers market are the technological advancement and growing population of senior citizens who are highly susceptible to bone-related ailments. This market has been segmented on the basis of end user, technology, type, and lastly, region. Based on end users, this market has been segmented into academic & research institutes, diagnostic centers, hospitals, specialty clinics, and others. The technology-based segmentation segments the market into dual-energy X-Ray absorptiometry (DXA), quantitative computed tomography (QCT), radiographic absorptiometry (RA), single X-Ray absorptiometry (SXA), and others. High quality scanner machines are making these technologies more reliable. By types, the market has been segmented into central scanners, peripheral scanners, and others.

The regional segmentation of the global bone densitometers market into the continent-based regional markets namely The Americas (North America & South America), Europe, Asia Pacific, and the Middle East & Africa (MEA). The Americas segment is the largest regional market for bone densitometers because of technological advancement. North America as a market is bigger than South America due to the availability of more advanced technology. The American market for bone densitometers is expected to reach around US $ 650 mn by the end of the forecast period. In North America, the most powerful economy is the United States of America (USA). Dalios Denture and Hearing Clinic in Chatham and Starkey Hearing Technologies have donated $6,000 towards the Foundation of Chatham-Kent Health Alliance’s Diagnostic Imaging Equipment Renewal Campaign. The funds will be used to purchase diagnostic medical equipment for Chatham-Kent that includes a bone densitometer, and a just-installed SPECT-CT scanner.

Europe is the second largest market. It has a high density of population, but in terms of technological advancement, it lags behind North America. The most important country-specific market are France, Germany, Italy, Spain, and the United Kingdom (UK), followed by the rest of Europe. According to the report, Asia Pacific region is expected to be a fastest growing region in the bone densitometers market during the forecast period. The significant country-specific markets in this region are China, India, Japan, and South Korea, followed by the rest of the Asia Pacific region. In the Asia Pacific, there are few countries that are technologically advanced. In the MEA region, the market is limited. Reasons for the limited market growth in this region are lack of awareness, lack of education, lack of technological development, political instability, and healthcare not considered a priority by majority governments in this region.

Key Players

The key players in the global bone densitometers market include Aarna Systems And Wellness Pvt. Ltd. (India), DMS Imaging (France), Echolight SPA (Italy), General Electric Company (USA), Hologic, Inc. (the USA), MedWrench LLC (USA), Osteosys Co. Ltd (South Korea), Schick Sirona (USA), Swissray (USA), and Tecnicare Healthcare Company (USA).

Get an Exclusive Discount on Report @ https://www.marketresearchfuture.com/check-discount/2300

Urinary Tract Infection (UTI) Market Revenue, Key Players, Supply-Demand, Investment Feasibility and Forecast to 2023

Market Scenario:

Urinary tract infection (UTI treatment) is the infection of the lower or upper urinary tract caused by bacterial agents such as Escherichia coli, Staphylococcus saprophyticus, and others. The symptoms associated with UTI are pain during urination, frequent urination and a feeling of urination despite having an empty bladder.

Global Urinary tract infection (UTI) treatment market is valued at USD 8 billion in 2016, which is expected to reach to USD 9.89 billion in 2023 at a CAGR of 3.6%.

Key players:

Some of the dominant vendors operating in the report are Bayer AG, GlaxoSmithKline Novartis AG, Dr. Reddy’s Laboratories Ltd., Pfizer Inc., F. Hoffmann-La Roche Ltd, AstraZeneca, Cipla Inc., Johnson & Johnson, and others.

Request Free Sample @ https://www.marketresearchfuture.com/sample_request/6138

Rise In Risk Factors Is The Prime Reason For Market Growth

The increase in risk factors for the UTI treatment market is unsafe sexual intercourse, especially anal sex which favors transfer of infection, diseases such as diabetes which results in lowering of immunity, obesity and a lack of hygiene and others. The incidence rate of UTIs is 0.91 % of total population and 2.05 % for a female population with E.coli being the most common pathogen accounting for 80 % to 90 % of all the cases.

Growth In Awareness Regarding Women Health And The High Economic Cost Of The Disease Is Driving A Large Demand

The World Health Organization (WHO) estimates that approximately  50 % of the women suffer from UTI issues at some point in their lives resulting in more than 1 million hospitalizations per year. Nearly 1 % of boys and 3 to 8 % of girls are diagnosed with UTI treatment. The annual cost of UTI treatment infections treatment is higher than $1 billion in the U.S. alone. Rise in hospital-borne infections, the emergence of drug-resistant bacteria, growing geriatric population, childbirth, and increasing health awareness especially about women health. According to Centres for Disease Control and Prevention among hospitals acquired infections, approximately 75 % are associated with a urinary catheter.

Growth Of Drug Resistance, Loss Of Patents, Coupled With Increasing Market Fragmentation May Hamper The Market Growth

The prime market constraints include growing drug resistance, unmet clinical needs, loss of patents, increasing market fragmentation, and others.

Segments:

To generate a bird’s view of the global urinary tract infection market, the report is segmented based on drug class, clinical indications, end users, and regions.

Based on drug class, the market is comprised of quinolones, aminoglycosides, β-lactam, azoles, and others.

Based on clinical indications, this market is segmented into urethritis, cystitis, and pyelonephritis and others.

Based on end users the market is segmented into hospitals, self-administered and others.

Based on the regions, the market is segmented as North America, Europe, Asia Pacific Middle East and Africa and rest of the world.

Regional analysis:

North America led by the U.S. accounts for the maximum market share of the global UTI treatment market followed by Europe. The recent regulatory shift in the U.S. such as the implementation of Affordable Care Act and Hospital Readmissions Reduction Program coupled with Medicare initiative to penalize unnecessary patient readmissions is expected to charge the U.S UTI treatment market. Europe has a higher hospitalization rate than the U.S. despite the U.S. having substantial spending on healthcare.

However, these markets are stagnant, and there is a definite shift towards the Asia Pacific regions led by India and China. The Asia Pacific will be the fastest growing market, and the growth will be driven by China, and India as these nations have colossal population and the low cost of UTI treatment drugs.

Get an Exclusive Discount on Report @ https://www.marketresearchfuture.com/check-discount/6138

Epigenetics Market Report to Share Estimated Growth Rate from 2023

Market Scenario:

Epigenetics is the analysis and study of heritable changes in gene function not involving changes in the DNA sequence such as changes in a chromosome, phenotypic affecting gene activity, and expression.

The global epigenetics market is valued at USD 800 million in 2016 and is expected to expand at a 12.9 % CAGR during the study period of 2016 to 2023.

Request Free Sample @ https://www.marketresearchfuture.com/sample_request/6161

Market Dynamics:

Oncology Segment Is Expected To Be The Largest Driver Of Market Growth

The growing incidence of cancer is the prime drivers of the market. According to W.H.O. cancer was responsible for 8.8 million deaths in 2015, indenting nearly 1 in 6 patient’s deaths. Common carcinomas are lung cancer, liver cancer, colorectal cancer, stomach cancer, and breast cancer, recording 1.69 million, 788,000, 774 thousand, 754 thousand, and 571 thousand deaths respectively in the year 2015. According to the estimates of the Centers for Disease Control and Prevention, almost 1.5 million people are diagnosed with cancer per year in the U.S. alone, resulting in more than five lakh deaths.

Technology Development Is Expected To Drive A Faster Market Adoption

The development of highly sensitive and selective tests, instrumentation and a concurrent rise in computational power is driving a broad adoption. The advancements such as the development of DNA and RNA modifying enzymes such as acetylases, methyltransferases, reverse transcriptase, ligases, and other protein-modifying enzymes has generated tremendous enthusiasm and concurrent faster market adoption.

The growing government support for biotechnology and growing partnership between academia and industry is another driver of growth. Attractive and critical advantages of technology exemplified by high-throughput molecular analysis of tissues, such as quick, cost-effective, efficient for less labor intensive and requires a lesser number of steps are the operational and economic driving factors of the market. Other technological developments include automation, advances in PCR technology, strategic and cross-functional nature of the molecular diagnostic technology and others.

High Cost Of Installation And Maintenance And Nascent Stage Of Technology May Hamper The Market Growth

The prime market constraints include prohibitive costs of molecular diagnostics, the high cost of manufacturing, consolidated nature of the market has put a premium on the price of the epigenetics products, nascent stage of technology and high power of firms relative to buyers.

Segments:

To generate a bird’s view of the global epigenetics market, the report is segmented based on instruments, consumables, applications, technology, end users, and regions.

Based on instruments, the market comprises of NGS, spectrometer, PCR, software solutions and others.

Based on consumables, the market comprises of kit, enzymes, reagent, and others.

Based on application, the market comprises of oncology, developmental biology, drug discovery, cardiology, immunology, and others.

Based on technology, the market comprises of methylation, histone modification, and others.

Based on end users the market is segmented into academia and research, pharmaceutical and biotechnology industry and others.

Based on the regions, the market is segmented as North America, Europe, Asia Pacific Middle East and Africa and rest of the world.

Regional analysis:

North America led by the U.S. accounts for the most significant market share of the market, owing to faster technology uptake, the large biotech sector of the U.S., the presence of large advanced players, growing prevalence of cancer.

Europe led by Germany, U.K., and France accounts for the second-largest and second fastest market during the forecasted period. Asia led by Japan and supported by China, South Korea, and India is anticipated to be the fastest growing market.

The Middle East and Africa market will expand at a slower rate on account of the weak industry landscape and low demand due to weak economic conditions.

Key Vendors:

Some of the dominant vendors operating in the report are Bio-Rad (US), Illumina (US), QIAGEN (Netherlands), Thermo Fisher (US), Active Motif (US), Diagenode (Belgium), Agilent (US), Merck Millipore (US), Abcam (UK), New England Biolabs (US), PerkinElmer (US), Zymo Research (US), and others.

Access Report @ https://www.marketresearchfuture.com/upcoming-reports/epigenetics-market-6161

Blockchain Technology in Healthcare Market Size By 2023 | Global Industry Share, Growth, Analysis, Company Profiles

Market Highlights:

Blockchain technology is decentralized platform system which allows real time transaction entry. It works as a digital ledger and allows users to track all the activities carried out in network. Factors that are propelling the growth of the global blockchain technology in healthcare market are rising cases of data breach and concerns related to data security, increasing demand for easy to use and inexpensive data management tools, Increasing investment in healthcare  and surge in adoption of blockchain technology. Moreover, increasing adoption of blockchain technology in healthcare sector is likely to provide favorable conditions for the growth of the market. For instance, in June 2018,In UK leading blockchain company, The Guardtime has launched health record platform which works on blockchain technology.

The lack of significant entity and universal standards for blockchain transactions, and lack of awareness about are likely to hinder market growth during the forecast period.

Request Free Sample @ https://www.marketresearchfuture.com/sample_request/6475

Regional Analysis:

The American market is expected to dominate the global blockchain technology in healthcare market during the forecast period due to the high adoption rate of advance technology, availability of large patient pool, presence of well-established healthcare management systems, rising healthcare expenditure, and insurance holders. According to the Committee for a Responsible Federal Budget, in year 2017, United states spent more than USD 3.5 trillion on healthcare expenditure, which is around 18% of the total GDP of nation. 

The European market is expected to be the second-largest due to increasing number of clinical trials with increasing research and development expenditure in pharmaceutical industry, increasing awareness about blockchain technology in the region, and rising healthcare expenditure.

Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the increasing generic pharmaceutical industry in the region, continuously increasing investment in healthcare, and adoption of technology in healthcare.

 The market in the Middle East & Africa is likely to account for the smallest share of the global blockchain technology in healthcare market.

Segmentation:

The Global Blockchain Technology in Healthcare Market has been segmented on the basis of application, type, and end-user.

The application segment has been segregated on the basis of supply chain management, patient data management, drug traceability, clinical trials & data security, claims adjudication, billing, and others.

On the basis of type, the market has been classified as permissioned blockchains, permission less blockchains.

The market, by end user, has been segmented into pharmaceutical companies,  healthcare service providers, healthcare consumers, and others

Access Report @ https://www.marketresearchfuture.com/upcoming-reports/blockchain-technology-healthcare-market-6475

Key Players:

Some of the key players in the global blockchain technology in healthcare market are IBM, Microsoft, Guardtime, Pokitdok , Gem, Patientory, Hashed Health, Chronicled, Isolve, Factom, Blockpharma, Medicalchain, Simplyvital Health,Farmatrust, and others

DNA Sequencing Market Plying for Significant Growth By 2023

Market Highlights

DNA sequencing contains information about genetically determined illness and IQ level of human beings. Increasing adoption of precision medicines and increasing use of other applications such as biotechnology, forensic biology, virology, and molecular biology are factors which are driving the growth of this market. The rise in investment in research and development enhances the demand for DNA sequencing and hence helps to increase market growth. The enzymic method for DNA sequencing has been used for genomic research and as accurate results were obtained by this method the demand for DNA sequencing has increased. This demand has driven the development of the second-generation sequencing method.

However, the lack of reimbursement policies in various countries across the world may limit the growth of this market during the forecast period.       

Request Free Sample @ https://www.marketresearchfuture.com/sample_request/5774

Regional Analysis

The market in the Americas is expected to boost the global DNA sequencing market owing to technological advancements and increasing incidences of genetic disorders among patients. Increasing investments by government organizations in the research and development of DNA sequencing are also boosting the market growth in this region. The European market is expected to be the second-largest due to government funding and support from the healthcare sector coupled with the rising prevalence of the genetic disorder. However, Asia-Pacific is projected to dominate in terms of growth rate over the forecast period owing to the rising investment towards R&D activities and unhealthy lifestyle which are resulting in an increased prevalence of cancer and other disorders. Rising geriatric population and increasing prevalence of tumor among patients in this region have a positive influence on the development of DNA sequencing market in this region.  The Middle East and Africa accounts for the smallest share due to lack of medical technology and poor medical facilities. Emerging economies such as India and China are leading to growth in the demand for DNA sequencing owing to an increasing number of healthcare awareness programs, government investments in healthcare, and favorable healthcare insurance coverage.  

Segmentation

The global DNA sequencing market has been segmented on the basis of type, product, technology, application, and end-users. On the basis of type, the market is segmented into instruments and consumables services and workflow products. Based on product the market is segmented into sequencing services and sequencing instruments and consumables. Sequencing instruments and consumables are further sub-segmented into two types such as sequencing instruments and consumables by product type and by platform type. Sequencing instruments and consumables by product type are further sub-segmented into consumables, instruments, whereas sequencing instruments and consumables by platform type are further sub-segmented into NGS, sanger, bioinformatics, sample prep kits, and reagents. On the basis of technology, the market is further segmented into semiconductor sequencing, pyrosequencing, sequencing by synthesis, single-molecule real-time sequencing (SMRT), sequencing by ligation (SBL), and other technologies. On the basis of application, the market is further segmented into diagnostics, agriculture and animal research, biomarker discovery, personalized medicine, drug discovery, and other applications. Based on end-user, the market is segmented into research centers and government institutes and academia, biotechnology and pharmaceutical companies, clinics and hospitals, and other end-users.

The DNA sequencing market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa.

Key Players

Some of the key players in the global DNA sequencing market are Perkin Elmer, Roche Holdings AG, Siemens AG, Illumina, Agilent Technologies Inc., Genia Corporation, Oxford Nanopore technologies, Koninklijke Philips N.V., Pacific Biosciences, Johnson & Johnson, Deep Genomics, Inc., Life Technologies, Illumina, Eppendorf, Tecan, and Thermo Scientific, Hamilton Thorne Biosciences, General Electric Company, Siemens Healthineers GmbH, Myriad Genetics, Bayer Corporation, Beckman Coulter, and others.

Access Report @ https://www.marketresearchfuture.com/reports/dna-sequencing-market-5774

Vascular Closure Devices Market Is Expected To Grow At A CAGR Of 6.8% By 2023

Market Highlights

It is estimated that the global vascular closure devices market is expected to register a CAGR ~ 6.8% during the forecast period of 2018–2023. The global vascular closure devices market is expected to witness tremendous growth owing to the rising prevalence of numerous types of cardiovascular as well as neurovascular diseases. Other key factors such as the untapped market opportunities in emerging countries, growing investments by government organizations, increasing adoption rate of minimally invasive techniques are contributing towards the growth of the market. However, factors such as lack of trained medical professionals, and the post-operative complications are expected to curb the growth of the market during the forecast period.

Request Free Sample @ https://www.marketresearchfuture.com/sample_request/5704

On the regional basis, the vascular closure devices market in the Americas is predicted to dominate the market during the forecast period. The North American region holds substantial share in the global market. This owes to the rise in the government initiatives, and the increased prevalence of coronary diseases in these regions. For instance, according to the data published in 2015 by the American Heart Association (AHA), about one in 7 deaths in the US is caused by coronary heart disease. Also, numerous major players are based in the US, owing to which the US has become a center for innovation in the vascular closure devices market.

Currently, the global vascular closure devices market is dominated by numerous players. The major players in this market are involved in new product launches, strategic partnerships and collaborations to increase their product portfolio. For example, in June 2018, Biomerics, a medical device contract manufacturer announced the acquisition of FutureMatrix Interventional, Inc. The company aims to expand its portfolio of interventional catheters used in cardiovascular and urology fields, thus strengthening its position in the market.

The global vascular closure devices market is segmented on the basis of product type, access, procedures, application, and end user.

Some of the key players in the global intraocular lens market are Abbott Laboratories, Terumo Corporation, Cardinal Health Inc., Cardiva Medical Inc., Morris Innovative, Inc., Medtronic plc, Essential Medical, Inc., Merit Medical Systems, Inc., TZ Medical, Inc., Vasorum Ltd., Transluminal Technologies LLC, Vascular Closure Systems, Inc., Vivasure Medical Ltd., among others.

Access Report Details @ https://www.marketresearchfuture.com/reports/vascular-closure-devices-market-5704